Warum geht Aastrom so in Keller? - 500 Beiträge pro Seite

[gony2]

wo doch der Conterpart Stemcells stetig steigt?

[Datteljongleur]

Antwort auf Beitrag Nr.: 40.583.448 von gony2 am 24.11.10 16:37:40

What goes up must come down!

[gony2]

Antwort auf Beitrag Nr.: 40.584.342 von Datteljongleur am 24.11.10 17:59:07

Yes, aber mit Grund oder nur durch Zockerrei?

Naja mal beobachten

[Datteljongleur]

Antwort auf Beitrag Nr.: 40.584.981 von gony2 am 24.11.10 19:21:58

So wie es aussieht durch Zockerei.
Schau mal ins Yahoo-Board (yahoo.com), da wird eifrig diskutiert!

[gony2]

Antwort auf Beitrag Nr.: 40.585.078 von Datteljongleur am 24.11.10 19:35:55

DOW JONES NEWSWIRES

Aastrom Biosciences Inc. (ASTM) unveiled details of its planned equity sale, raising some $20 million from the effort.

Shares tumbled 25% to $2.30 in premarket action. As of Thursday's close, the stock had risen 25% this year.

The emerging biotechnology company, whose market value was about $85 million as of Thursday, will sell at least 10 million units, each made up of one share and a warrant to buy another, at $2.25 each. The deal's potential size wasn't disclosed when Aastrom announced its plans Thursday.

The company, which has about 21 million shares outstanding, plans to use the proceeds from the offering for purposes including research-and-development and capital expenditures. Aastrom joins a host of bio-focused companies that have sold fresh equity to fund research and clinical trial expenses.

It develops expanded autologous cellular therapies for use in the treatment of severe, chronic and cardiovascular diseases. Aastrom has advanced its cell therapies into late-stage clinical development, including a planned Phase 3 clinical program for the treatment of patients with critical limb ischemia.

-By Nathan Becker, Dow Jones Newswires; 212-416-2855; [e-mail]

[Pantherwoods]

Aastrom Biosciences wird aktuell wieder sehr interessant!
heute stieg PSTI (Pluristem Therapeutics) erneut um 20%, allein aufgrund neuer zulassung weiterer trials. für ASTM steht jeden moment die bekanntgabe einer phase III studie an - soweit ist noch niemand weltweit! diesen donnerstag wird es besonders spannend - http://www.aastrom.com/eventdetail.cfm?eventid=91103

zu PIII aktuell:
http://www.dailyfinance.com/rtn/pr/aastrom-receives-fda-fast…

Analyse aktuell:
http://seekingalpha.com/article/245744-aastrom-biosciences-h…

<div style="width:477px" id="__ss_6460446"><strong style="display:block;margin:12px 0 4px"><a href="http://www.slideshare.net/pslice84/astm-restore-cli-update-nov-2010" title="Astm restore cli update nov 2010">Astm restore cli update nov 2010</a></strong><object id="__sse6460446" width="477" height="510"><param name="movie" value="http://static.slidesharecdn.com/swf/doc_player.swf?doc=astmrestore-cliupdatenov2010-110105124758-phpapp01&stripped_title=astm-restore-cli-update-nov-2010&userName=pslice84" /><param name="allowFullScreen" value="true"/><param name="allowScriptAccess" value="always"/><embed name="__sse6460446" src="http://static.slidesharecdn.com/swf/doc_player.swf?doc=astmrestore-cliupdatenov2010-110105124758-phpapp01&stripped_title=astm-restore-cli-update-nov-2010&userName=pslice84" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" width="477" height="510"></embed></object><div style="padding:5px 0 12px">View more <a href="http://www.slideshare.net/">documents</a> from <a href="http://www.slideshare.net/pslice84">Chasing the Alpha</a>.</div></div>

[Pantherwoods]

http://finance.yahoo.com/news/Aastrom-Biosciences-receives-a…

die 3$ marke wird seit einigen tagen erfolgreich gehalten.